(Q79361043)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Shingo Akikusa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hiroaki Okuno

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Masato Kodaka

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

639-646

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669795%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1027362507683

21 December 2019

exact match

0 references

cites work

Breast cancer cells interact with osteoblasts to support osteoclast formation

1 reference

12 December 2020

Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites

1 reference

12 December 2020

Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones

1 reference

12 December 2020

Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements

1 reference

12 December 2020

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

1 reference

12 December 2020

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines

1 reference

12 December 2020

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma

1 reference

12 December 2020

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

12 December 2020

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands

1 reference

12 December 2020

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis

1 reference

12 December 2020

Significance of VLA-4-VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model

1 reference

12 December 2020

1 reference

12 December 2020

A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function

1 reference

12 December 2020

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

12 December 2020

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

12 December 2020

Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.

1 reference

12 December 2020

Chinese hamster ovary cells expressing alpha4beta1 integrin stimulate osteoclast formation in vitro.

1 reference

12 December 2020

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

1 reference

12 December 2020

Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis

1 reference

12 December 2020

Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells

1 reference

12 December 2020

Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone

1 reference

12 December 2020

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

1 reference

12 December 2020

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

1 reference

12 December 2020

Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells

1 reference

12 December 2020

Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice

1 reference

12 December 2020

Human bone marrow myeloma cells express RANKL

1 reference

12 December 2020

Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

1 reference

12 December 2020

Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells

1 reference

12 December 2020

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

12 December 2020

Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose

1 reference

12 December 2020

RANK ligand and osteoprotegerin in myeloma bone disease.

1 reference

12 December 2020

Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro

1 reference

12 December 2020

Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects

1 reference

12 December 2020

Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice

1 reference

12 December 2020

Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.

1 reference

12 December 2020

Transforming growth factor-beta induces expression of receptor activator of NF-kappa B ligand in vascular endothelial cells derived from bone

1 reference

12 December 2020

IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae

1 reference

12 December 2020

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression

1 reference

12 December 2020

Immunocytochemistry reveals RANKL expression of myeloma cells

1 reference

12 December 2020

Association between ICAM-1 expression and metastatic capacity of murine B-cell hybridomas

1 reference

12 December 2020

Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells

1 reference

12 December 2020

Expression of Retrovirally Transduced IL-1 α in IL-6-Dependent B Cells: A Murine Model of Aggressive Multiple Myeloma

1 reference

12 December 2020